Abstract
Abstract: Almotriptan is a selective serotonin agonist used for the relief of moderate to severe migraine headaches. Clinical trials have begun to evaluate its use in the ‘early’ treatment of migraines, described as when a triptan is administered within 1 hour of the onset of headache for mild pain. These trials have demonstrated higher pain-free rates, decreased recurrence of migraines, and a reduction in the need for rescue medication compared to when the treatment is delayed until the pain is moderate to severe in intensity or beyond 1 hour of headache onset. Tolerability and safety of almotriptan for 'early' use is similar to standard administration of the medication.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
